Years Active: 2025
Title: Chase Hudson: Innovator in Pharmaceutical Aqueous Therapeutic Particles
Introduction
Chase Hudson is a notable inventor based in Provo, UT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of aqueous therapeutic particles. Her innovative approach has the potential to enhance the bioavailability of various therapeutic substances.
Latest Patents
Chase Hudson holds a patent for a process titled "Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness." This invention focuses on creating pharmaceutical aqueous therapeutic particles (AQTP) that possess stable exterior water clustering with a nanosized thickness of less than 300 nanometers. The AQTP developed through this process demonstrates improved bioavailability when administered to mammals compared to conventional pharmaceutical drug particles.
Career Highlights
Throughout her career, Chase has been dedicated to advancing pharmaceutical technologies. Her work emphasizes the importance of efficiency and consistency in the production of therapeutic particles. The improved process apparatus she developed is computer-controlled and capable of continuous operation, which enhances the overall quality of the AQTP.
Collaborations
Chase Hudson has collaborated with notable individuals in her field, including Karl P Dresdner, Jr and Michael Raymond Cary. These partnerships have contributed to the refinement and success of her innovative processes.
Conclusion
Chase Hudson's contributions to the field of pharmaceuticals through her patented processes highlight her role as a pioneering inventor. Her work not only advances therapeutic particle technology but also opens new avenues for improved medical treatments.